Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Obesity as a Potential Risk Factor for Vincristine-induced Peripheral Neuropathy.

Sajdyk TJ, Boyle FA, Foran KS, Tong Y, Pandya P, Smith EML, Ho RH, Wells E, Renbarger JL.

J Pediatr Hematol Oncol. 2019 Oct 18. doi: 10.1097/MPH.0000000000001604. [Epub ahead of print]

PMID:
31634238
2.

Gene Co-Expression Networks Restructured Gene Fusion in Rhabdomyosarcoma Cancers.

Helm BR, Zhan X, Pandya PH, Murray ME, Pollok KE, Renbarger JL, Ferguson MJ, Han Z, Ni D, Zhang J, Huang K.

Genes (Basel). 2019 Aug 30;10(9). pii: E665. doi: 10.3390/genes10090665.

3.

Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.

Cheng L, Pandya PH, Liu E, Chandra P, Wang L, Murray ME, Carter J, Ferguson M, Saadatzadeh MR, Bijangi-Visheshsaraei K, Marshall M, Li L, Pollok KE, Renbarger JL.

BMC Med Genomics. 2019 Jan 31;12(Suppl 1):23. doi: 10.1186/s12920-018-0456-5.

4.

Genetic Variants Associated With Vincristine-Induced Peripheral Neuropathy in Two Populations of Children With Acute Lymphoblastic Leukemia.

Li L, Sajdyk T, Smith EML, Chang CW, Li C, Ho RH, Hutchinson R, Wells E, Skiles JL, Winick N, Martin PL, Renbarger JL.

Clin Pharmacol Ther. 2019 Jun;105(6):1421-1428. doi: 10.1002/cpt.1324. Epub 2019 Jan 21.

PMID:
30506673
5.

CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancer.

Skiles JL, Chiang C, Li CH, Martin S, Smith EL, Olbara G, Jones DR, Vik TA, Mostert S, Abbink F, Kaspers GJ, Li L, Njuguna F, Sajdyk TJ, Renbarger JL.

Pediatr Blood Cancer. 2018 Mar;65(3). doi: 10.1002/pbc.26854. Epub 2017 Nov 8.

6.

Low serum albumin levels prior to pediatric allogeneic HCT are associated with increased need for critical care interventions and increased 6-month mortality.

Teagarden AM, Skiles JL, Beardsley AL, Hobson MJ, Moser EAS, Renbarger JL, Rowan CM.

Pediatr Transplant. 2017 Sep;21(6). doi: 10.1111/petr.13016. Epub 2017 Jul 2.

7.

Weight gain and supplemental O2 : Risk factors during the hematopoietic cell transplant admission in pediatric patients.

Rowan CM, Nitu ME, Moser EAS, Swigonski NL, Renbarger JL.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26561. Epub 2017 Apr 25.

PMID:
28439949
8.

IODNE: An integrated optimization method for identifying the deregulated subnetwork for precision medicine in cancer.

Mounika Inavolu S, Renbarger J, Radovich M, Vasudevaraja V, Kinnebrew GH, Zhang S, Cheng L.

CPT Pharmacometrics Syst Pharmacol. 2017 Mar;6(3):168-176. doi: 10.1002/psp4.12167. Epub 2017 Mar 7. Review.

9.

Glutathione-S-transferase P1 may predispose children to a decline in pulmonary function after stem cell transplant.

Stark J, Renbarger J, Slaven J, Yu Z, Then J, Skiles J, Davis S.

Pediatr Pulmonol. 2017 Jul;52(7):916-921. doi: 10.1002/ppul.23678. Epub 2017 Feb 2.

10.

The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches.

Pandya PH, Murray ME, Pollok KE, Renbarger JL.

J Immunol Res. 2016;2016:4273943. doi: 10.1155/2016/4273943. Epub 2016 Dec 26. Review.

11.

Use of Precision Medicine Molecular Profiling of Baseline Tumor Specimen May Not Benefit Outcomes in Children With Relapsed or Refractory Pediatric Sarcomas.

Carter J, Cheng L, Zucker J, Marshall M, Pollok K, Murray M, Li L, Renbarger J.

Clin Pharmacol Ther. 2017 Mar;101(3):328-330. doi: 10.1002/cpt.599. No abstract available.

12.

Differential effects of hydrocortisone, prednisone, and dexamethasone on hormonal and pharmacokinetic profiles: a pilot study in children with congenital adrenal hyperplasia.

Nebesio TD, Renbarger JL, Nabhan ZM, Ross SE, Slaven JE, Li L, Walvoord EC, Eugster EA.

Int J Pediatr Endocrinol. 2016;2016:17. doi: 10.1186/s13633-016-0035-5. Epub 2016 Sep 26.

13.

Identifying Genetic Variants in Adolescents With Oppositional Defiant Disorders and/or Conduct Disorders: A Brief Report.

Oruche UM, Ross SE, Carpenter JS, Renbarger J.

J Child Adolesc Psychiatr Nurs. 2016 Aug;29(3):154-7. doi: 10.1111/jcap.12153.

14.

Hypoxia-Inducible Factor-1α Regulates CD55 in Airway Epithelium.

Pandya PH, Fisher AJ, Mickler EA, Temm CJ, Lipking KP, Gracon A, Rothhaar K, Sandusky GE, Murray M, Pollok K, Renbarger J, Blum JS, Lahm T, Wilkes DS.

Am J Respir Cell Mol Biol. 2016 Dec;55(6):889-898.

15.

Raising the Level of Nursing Involvement in the National Precision Medicine Initiative: An Example.

Oruche UM, Carpenter JS, Renbarger J, Ross SE.

J Child Adolesc Psychiatr Nurs. 2016 May;29(2):85-8. doi: 10.1111/jcap.12141. Epub 2016 May 25.

16.

Simultaneous quantification of mycophenolic acid and its glucuronide metabolites in human plasma by an UPLC-MS/MS assay.

Zhang D, Chow DS, Renbarger JL.

Biomed Chromatogr. 2016 Oct;30(10):1648-55. doi: 10.1002/bmc.3736. Epub 2016 May 9.

PMID:
27061819
17.

Pharmacokinetic Variability of Mycophenolic Acid in Pediatric and Adult Patients With Hematopoietic Stem Cell Transplantation.

Zhang D, Renbarger JL, Chow DS.

J Clin Pharmacol. 2016 Nov;56(11):1378-1386. doi: 10.1002/jcph.745.

18.

Differences in Circulating Endothelial Progenitor Cells among Childhood Cancer Survivors Treated with and without Radiation.

Pradhan K, Mund J, Case J, Gupta S, Liu Z, Gathirua-Mwangi W, McDaniel A, Renbarger J, Champion V.

J Hematol Thromb. 2015 Aug;1(1). pii: 4. Epub 2015 Aug 5.

19.

Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation.

Akil A, Zhang Q, Mumaw CL, Raiker N, Yu J, Velez de Mendizabal N, Haneline LS, Robertson KA, Skiles J, Diaz-Ricart M, Carreras E, Renbarger J, Hanash S, Bies RR, Paczesny S.

Biol Blood Marrow Transplant. 2015 Oct;21(10):1739-45. doi: 10.1016/j.bbmt.2015.07.004. Epub 2015 Jul 11.

20.

Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.

Lavoie Smith EM, Li L, Chiang C, Thomas K, Hutchinson RJ, Wells EM, Ho RH, Skiles J, Chakraborty A, Bridges CM, Renbarger J.

J Peripher Nerv Syst. 2015 Mar;20(1):37-46. doi: 10.1111/jns.12114.

21.

Opportunities and challenges of proteomics in pediatric patients: circulating biomarkers after hematopoietic stem cell transplantation as a successful example.

Paczesny S, Duncan C, Jacobsohn D, Krance R, Leung K, Carpenter P, Bollard C, Renbarger J, Cooke K.

Proteomics Clin Appl. 2014 Dec;8(11-12):837-50. doi: 10.1002/prca.201400033. Epub 2014 Oct 30. Review.

22.

Revitalizing personalized medicine: respecting biomolecular complexities beyond gene expression.

Jayachandran D, Ramkrishna U, Skiles J, Renbarger J, Ramkrishna D.

CPT Pharmacometrics Syst Pharmacol. 2014 Apr 16;3:e110. doi: 10.1038/psp.2014.6.

23.

Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.

Lavoie Smith EM, Li L, Hutchinson RJ, Ho R, Burnette WB, Wells E, Bridges C, Renbarger J.

Cancer Nurs. 2013 Sep-Oct;36(5):E49-60. doi: 10.1097/NCC.0b013e318299ad23.

24.

Pharmacogenetic predictors of nausea and vomiting of pregnancy severity and response to antiemetic therapy: a pilot study.

Lehmann AS, Renbarger JL, McCormick CL, Topletz AR, Rouse C, Haas DM.

BMC Pregnancy Childbirth. 2013 Jun 20;13:132. doi: 10.1186/1471-2393-13-132.

25.

The relative contributions of CYP3A4 and CYP3A5 to the metabolism of vinorelbine.

Topletz AR, Dennison JB, Barbuch RJ, Hadden CE, Hall SD, Renbarger JL.

Drug Metab Dispos. 2013 Sep;41(9):1651-61. doi: 10.1124/dmd.113.051094. Epub 2013 Jun 18.

26.

The tumor suppressor CDKN3 controls mitosis.

Nalepa G, Barnholtz-Sloan J, Enzor R, Dey D, He Y, Gehlhausen JR, Lehmann AS, Park SJ, Yang Y, Yang X, Chen S, Guan X, Chen Y, Renbarger J, Yang FC, Parada LF, Clapp W.

J Cell Biol. 2013 Jun 24;201(7):997-1012. doi: 10.1083/jcb.201205125. Epub 2013 Jun 17. Erratum in: J Cell Biol. 2013 Aug 19;202(4):717.

27.

Nifedipine pharmacokinetics are influenced by CYP3A5 genotype when used as a preterm labor tocolytic.

Haas DM, Quinney SK, Clay JM, Renbarger JL, Hebert MF, Clark S, Umans JG, Caritis SN; Obstetric-Fetal Pharmacology Research Units Network.

Am J Perinatol. 2013 Apr;30(4):275-81. doi: 10.1055/s-0032-1323590. Epub 2012 Aug 8.

28.

Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients.

Yancey A, Harris MS, Egbelakin A, Gilbert J, Pisoni DB, Renbarger J.

Pediatr Blood Cancer. 2012 Jul 15;59(1):144-8. doi: 10.1002/pbc.24138. Epub 2012 Mar 19.

29.

Pharmacotherapy and pregnancy: highlights from the Third International Conference for Individualized Pharmacotherapy in Pregnancy.

Haas DM, Gallauresi B, Shields K, Zeitlin D, Clark SM, Hebert MF, Ren Z, Nallani SC, Meslin EM, Feibus KB, Koren G, Goebel WS, Easterling T, Denne SC, Flockhart DA, Renbarger JL.

Clin Transl Sci. 2011 Jun;4(3):204-9. doi: 10.1111/j.1752-8062.2011.00280.x.

30.

Dactinomycin and vincristine toxicity in the treatment of childhood cancer: a retrospective study from the Children's Oncology Group.

Langholz B, Skolnik JM, Barrett JS, Renbarger J, Seibel NL, Zajicek A, Arndt CA.

Pediatr Blood Cancer. 2011 Aug;57(2):252-7. doi: 10.1002/pbc.22882. Epub 2010 Dec 1.

31.

A pilot study of the impact of genotype on nifedipine pharmacokinetics when used as a tocolytic.

Haas DM, Quinney SK, McCormick CL, Jones DR, Renbarger JL.

J Matern Fetal Neonatal Med. 2012 Apr;25(4):419-23. doi: 10.3109/14767058.2011.583700. Epub 2011 Jun 7.

PMID:
21644845
32.

Collection of human genomic DNA from neonates: a comparison between umbilical cord blood and buccal swabs.

Lehmann AS, Haas DM, McCormick CL, Skaar TC, Renbarger JL.

Am J Obstet Gynecol. 2011 Apr;204(4):362.e1-6. doi: 10.1016/j.ajog.2010.12.013. Epub 2011 Feb 16.

33.

Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia.

Egbelakin A, Ferguson MJ, MacGill EA, Lehmann AS, Topletz AR, Quinney SK, Li L, McCammack KC, Hall SD, Renbarger JL.

Pediatr Blood Cancer. 2011 Mar;56(3):361-7. doi: 10.1002/pbc.22845. Epub 2010 Nov 11.

34.

Human breast milk as a source of DNA for amplification.

Haas DM, Daum M, Skaar T, Philips S, Miracle D, Renbarger JL.

J Clin Pharmacol. 2011 Apr;51(4):616-9. doi: 10.1177/0091270010370847. Epub 2010 May 24. No abstract available.

35.

Pharmacotherapy and pregnancy: highlights from the Second International Conference for Individualized Pharmacotherapy in Pregnancy.

Haas DM, Hebert MF, Soldin OP, Flockhart DA, Madadi P, Nocon JJ, Chambers CD, Hankins GD, Clark S, Wisner KL, Li L, Renbarger JL, Learman LA.

Clin Transl Sci. 2009 Dec;2(6):439-43. doi: 10.1111/j.1752-8062.2009.00166.x.

36.

Pharmacotherapy and pregnancy: Highlights from the first International Conference for Individualized Pharmacotherapy in Pregnancy.

Haas DM, Renbarger JL, Denne S, Ahmed MS, Easterling T, Feibus K, Meslin EM, Koren G, Zajicek A, Snodgrass WR, Flockhart DA.

Clin Transl Sci. 2009 Feb;2(1):11-4. doi: 10.1111/j.1752-8062.2009.00079.x. No abstract available.

37.

Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network study.

Thompson PA, Rosner GL, Matthay KK, Moore TB, Bomgaars LR, Ellis KJ, Renbarger J, Berg SL.

Cancer Chemother Pharmacol. 2009 Jul;64(2):243-51. doi: 10.1007/s00280-008-0854-z. Epub 2008 Nov 20.

PMID:
19020877
38.

Patient attitudes toward genotyping in an urban women's health clinic.

Haas DM, Renbarger JL, Meslin EM, Drabiak K, Flockhart D.

Obstet Gynecol. 2008 Nov;112(5):1023-8. doi: 10.1097/AOG.0b013e318187e77f.

PMID:
18978101
39.

Quantification of vincristine and its major metabolite in human plasma by high-performance liquid chromatography/tandem mass spectrometry.

Dennison JB, Renbarger JL, Walterhouse DO, Jones DR, Hall SD.

Ther Drug Monit. 2008 Jun;30(3):357-64. doi: 10.1097/FTD.0b013e31816b92c9.

PMID:
18520608
40.

Unrelated cord blood transplantation for severe congenital neutropenia: report of two cases with very different transplant courses.

Markel MK, Haut PR, Renbarger JA, Robertson KA, Goebel WS.

Pediatr Transplant. 2008 Dec;12(8):896-901. doi: 10.1111/j.1399-3046.2008.00951.x. Epub 2008 Apr 22.

PMID:
18433408
41.

Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients.

Renbarger JL, McCammack KC, Rouse CE, Hall SD.

Pediatr Blood Cancer. 2008 Apr;50(4):769-71.

PMID:
18085684
42.

Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis.

Bernardi RJ, Bomgaars L, Fox E, Balis FM, Egorin MJ, Lagattuta TF, Aikin A, Whitcomb P, Renbarger J, Lieberman FS, Berg SL, Blaney SM.

Cancer Chemother Pharmacol. 2008 Jul;62(2):355-61. Epub 2007 Oct 2.

PMID:
17909804
43.

Effect of CYP3A5 expression on vincristine metabolism with human liver microsomes.

Dennison JB, Jones DR, Renbarger JL, Hall SD.

J Pharmacol Exp Ther. 2007 May;321(2):553-63. Epub 2007 Feb 1.

PMID:
17272675
44.

Selective metabolism of vincristine in vitro by CYP3A5.

Dennison JB, Kulanthaivel P, Barbuch RJ, Renbarger JL, Ehlhardt WJ, Hall SD.

Drug Metab Dispos. 2006 Aug;34(8):1317-27. Epub 2006 May 5.

PMID:
16679390
45.

Plasma and cerebrospinal fluid pharmacokinetics of SU5416 after intravenous administration in nonhuman primates.

Renbarger J, Aleksic A, McGuffey L, Dauser R, Berg S, Blaney S.

Cancer Chemother Pharmacol. 2004 Jan;53(1):39-42. Epub 2003 Oct 9.

PMID:
14551735
46.

Pneumonia in the immunocompromised pediatric cancer patient.

Neville K, Renbarger J, Dreyer Z.

Semin Respir Infect. 2002 Mar;17(1):21-32. Review.

PMID:
11891516

Supplemental Content

Loading ...
Support Center